April 23, 2009

Biosig, a Canadian-based company, sued Nautilus in August 2004 alleging that various heart rate monitor devices sold by Nautilus with its exercise equipment infringe U.S. Patent Number 5,337,753.  Klarquist Sparkman assumed the defense of the case from Ropes Gray in 2008, and promptly moved to put the patent in reexaminination.  Following the grant of the reexamination request, the parties agreed to dismiss the case without prejudice on March 26, 2009.  In an early first office action, the PTO has now rejected all but one of the patent claims.

Attorneys Jim Geringer, Robert Scotti, and Rob Cruzen led Klarquist Sparkman’s efforts on behalf of Nautilus.

For more information on Klarquist Sparkman's reexamination practice click here.